Focused Watchlists
We narrow a large universe of drug trial events down to a smaller group of names worth watching more closely.
Our Product
What BioLensTracker Delivers
BioLensTracker is a subscriber product built to make Phase 3 drug trial events easier to follow, understand, and act on in your own research process.
Reasoning You Can Read
Subscribers get clear context on why a drug program made the list, grounded in Phase 2 abstract evidence.
Ongoing Alerts
Once a round is live, subscribers stay informed when key trial results are released and when the active list changes.
What Subscribers Receive
- • New-round emails and texts when a fresh list of picks goes live.
- • Short explanations covering the drug, disease, sponsor, and why the name stands out.
- • Outcome alerts when a monitored Phase 3 trial posts a confirmed pass or fail result.
- • A clear flow from picks to monitoring to final updates.